Biosimilars Market Worth $1954 Million by 2018 - New Report by ...

17-02-2014 PR WebComments (0)

Biosimilars

The “Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast ...

Read more on PR Web

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top